Connor, Clark & Lunn Investment Management (CC&L)’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $295K | Hold |
|
|||||
|
2022
Q2 | $257K | Hold |
|
|||||
|
2022
Q1 | $315K | Sell |
|
|||||
|
2021
Q4 | $232K | Hold |
|
|||||
|
2021
Q3 | $318K | Buy |
|
|||||
|
2021
Q2 | $317K | Sell |
|
|||||
|
2021
Q1 | $390K | Buy |
|
|||||
|
2020
Q4 | $1.12M | Sell |
|
|||||
|
2020
Q3 | $442K | Sell |
|
|||||
|
2020
Q2 | $602K | Sell |
|
|||||
|
2020
Q1 | $315K | Sell |
|
|||||
|
2019
Q4 | $947K | Sell |
|
|||||
|
2019
Q3 | $640K | Sell |
|
|||||
|
2019
Q2 | $863K | Sell |
|
|||||
|
2019
Q1 | $1.21M | Sell |
|
|||||
|
2018
Q4 | $963K | Sell |
|
|||||
|
2018
Q3 | $1.59M | Sell |
|
|||||
|
2018
Q2 | $3.21M | Buy |
|
|||||
|
2018
Q1 | $4.05M | Buy |
|
|||||
|
2017
Q4 | $3.67M | Buy |
|
|||||
|
2017
Q3 | $4.23M | Buy |
|
|||||
|
2017
Q2 | $878K | Buy |
|
|||||
|
2017
Q1 | $665K | Sell |
|
|||||
|
2016
Q4 | $417K | Sell |
|
|||||
|
2016
Q3 | $671K | Buy |
|
|||||
|
2016
Q2 | $320K | Buy |
|